Literature DB >> 17163483

Metabolism of chlorpyrifos and chlorpyrifos oxon by human hepatocytes.

Kyoungju Choi1, Hyun Joo, Randy L Rose, Ernest Hodgson.   

Abstract

The metabolism of chlorpyrifos (CPS) and chlorpyrifos oxon (CPO) by human hepatocytes and human liver S9 fractions was investigated using LC-MS/MS. Cytochrome P450 (CYP)-dependent and phase II-related products were determined following incubation with CPS and CPO. CYP-related products, 3,5,6-trichloro-2-pyridinol (TCP), diethyl thiophosphate, and dealkylated CPS, were found following CPS treatment and dealkylated CPO following CPO treatment. Diethyl phosphate was not identified because of its high polarity and lack of retention with the chromatographic conditions employed. Phase II-related conjugates, including O- and S-glucuronides as well as 11 GSH-derived metabolites, were identified in CPS-treated human hepatocytes, although the O-sulfate of TCP conjugate was found only when human liver S9 fractions were used as the enzyme source. O-Glucuronide of TCP was also identified in CPO-treated hepatocytes. CPS and CPO were identified using HPLC-UV after CPS metabolism by the human liver S9 fraction. However, CPO was not found following treatment of human hepatocytes with either CPS or CPO. These results suggest that human liver plays an important role in detoxification, rather than activation, of CPS. Copyright (c) 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17163483     DOI: 10.1002/jbt.20145

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  8 in total

1.  Enzymatic detoxification of organophosphorus pesticides and related toxicants.

Authors:  Karla Alejo-González; Erik Hanson-Viana; Rafael Vazquez-Duhalt
Journal:  J Pestic Sci       Date:  2018-02-28       Impact factor: 1.519

2.  Differential sensitivity of plasma carboxylesterase-null mice to parathion, chlorpyrifos and chlorpyrifos oxon, but not to diazinon, dichlorvos, diisopropylfluorophosphate, cresyl saligenin phosphate, cyclosarin thiocholine, tabun thiocholine, and carbofuran.

Authors:  Ellen G Duysen; John R Cashman; Lawrence M Schopfer; Florian Nachon; Patrick Masson; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2011-12-24       Impact factor: 5.192

3.  Microsomal biotransformation of chlorpyrifos, parathion and fenthion in rainbow trout (Oncorhynchus mykiss) and coho salmon (Oncorhynchus kisutch): mechanistic insights into interspecific differences in toxicity.

Authors:  Ramon Lavado; Daniel Schlenk
Journal:  Aquat Toxicol       Date:  2010-09-16       Impact factor: 4.964

4.  Differential phosphoprotein signaling in the cortex in mouse models of Gulf War Illness using corticosterone and acetylcholinesterase inhibitors.

Authors:  Julia A Penatzer; Julie V Miller; Nicole Prince; Misa Shaw; Cayla Lynch; Mackenzie Newman; Gerald R Hobbs; Jonathan W Boyd
Journal:  Heliyon       Date:  2021-07-12

5.  Glucosylation and Glutathione Conjugation of Chlorpyrifos and Fluopyram Metabolites Using Electrochemistry/Mass Spectrometry.

Authors:  Tessema Fenta Mekonnen; Ulrich Panne; Matthias Koch
Journal:  Molecules       Date:  2019-03-04       Impact factor: 4.411

Review 6.  Chlorpyrifos Occurrence and Toxicological Risk Assessment: A Review.

Authors:  Elżbieta Wołejko; Bożena Łozowicka; Agata Jabłońska-Trypuć; Marta Pietruszyńska; Urszula Wydro
Journal:  Int J Environ Res Public Health       Date:  2022-09-26       Impact factor: 4.614

7.  Extreme variability in the formation of chlorpyrifos oxon (CPO) in patients poisoned by chlorpyrifos (CPF).

Authors:  Florian Eyer; Darren M Roberts; Nicholas A Buckley; Michael Eddleston; Horst Thiermann; Franz Worek; Peter Eyer
Journal:  Biochem Pharmacol       Date:  2009-05-09       Impact factor: 5.858

8.  Protein tyrosine adduct in humans self-poisoned by chlorpyrifos.

Authors:  Bin Li; Peter Eyer; Michael Eddleston; Wei Jiang; Lawrence M Schopfer; Oksana Lockridge
Journal:  Toxicol Appl Pharmacol       Date:  2013-04-06       Impact factor: 4.219

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.